Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Free Cash Flow (2016 - 2025)

Palisade Bio has reported Free Cash Flow over the past 16 years, most recently at -$3.1 million for Q4 2025.

  • Quarterly Free Cash Flow fell 32.05% to -$3.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$10.8 million through Dec 2025, up 11.04% year-over-year, with the annual reading at -$10.8 million for FY2025, 11.04% up from the prior year.
  • Free Cash Flow was -$3.1 million for Q4 2025 at Palisade Bio, up from -$3.6 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$1.2 million in Q1 2021 and troughed at -$3.8 million in Q1 2022.
  • The 5-year median for Free Cash Flow is -$3.1 million (2024), against an average of -$2.9 million.
  • Year-over-year, Free Cash Flow plummeted 201.12% in 2022 and then skyrocketed 48.07% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$1.2 million in 2021, then tumbled by 165.28% to -$3.3 million in 2022, then rose by 17.19% to -$2.7 million in 2023, then grew by 13.29% to -$2.4 million in 2024, then tumbled by 32.05% to -$3.1 million in 2025.
  • Per Business Quant, the three most recent readings for PALI's Free Cash Flow are -$3.1 million (Q4 2025), -$3.6 million (Q3 2025), and -$1.8 million (Q2 2025).